Answers are grounded in this paper and cite their sources.
Case report demonstrates treatment of heparin-induced thrombocytopenia using rivaroxaban in a post-cardiac surgery patient, highlighting alternative oral anticoagulant strategies.
Heparin-induced thrombocytopenia (HIT) is an immunogenic disorder. It can lead to thrombocytopenia and a hypercoagulated state with an increased risk for new thrombosis. We here reported a 49-year-old man with previous cardiac surgery and heparin administration, treated by new oral anticoagulant agent, Rivaroxaban.
No takes yet. Share an insight, caveat, or question.
Eshraghi et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: